Literature DB >> 6824121

Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies.

S B Halstead, K Larsen, S Kliks, J S Peiris, J Cardosa, J S Porterfield.   

Abstract

Tissue culture-adapted dengue 2 virus (DEN 2), strain 16681, exhibits antibody-dependent enhancement of infection (ADE) in P388D1 cells, a mouse macrophage-like cell line. ADE is dependent upon maintaining DEN 2 multiplicity of infection at between 0.1 and 0.001, and can be simply measured in multi-well plastic plates. The assay uses either trypsinized or non-trypsinized P388D1 cells at 5 x 10(5) cells per ml, an appropriate dilution of DEN 2 virus, and a source of antibody, and is most conveniently performed without further washing of stationary cultures, which are incubated in 5% CO2. Trypsinization of P388D1 cells prior to the addition of virus-serum mixtures reduced infection in control cultures thus increasing ADE. When cells were washed after incubation of virus-serum mixtures for 1 hour, a paradoxical increase of infection in cultures exposed to virus plus normal serum was noted, which reduced the sensitivity of the ADE assay. Using human cord blood sera, ADE titers measured in human monocytes and P388D1 cells were closely similar. This convenient and economical assay will facilitate large scale biological and epidemiological studies of dengue virus enhancing antibodies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824121     DOI: 10.4269/ajtmh.1983.32.157

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies.

Authors:  Z Jianmin; M L Linn; R Bulich; M K Gentry; J G Aaskov
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus.

Authors:  J S Salas-Benito; R M del Angel
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.

Authors:  Y M Zhang; E P Hayes; T C McCarty; D R Dubois; P L Summers; K H Eckels; R M Chanock; C J Lai
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

4.  Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.

Authors:  Kobporn Boonnak; Kaitlyn M Dambach; Gina C Donofrio; Boonrat Tassaneetrithep; Mary A Marovich
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection.

Authors:  J J Martínez-Barragán; R M del Angel
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes.

Authors:  J F Bukowski; I Kurane; C J Lai; M Bray; B Falgout; F A Ennis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Molecular mechanism of pathogenesis of dengue virus: Entry and fusion with target cell.

Authors:  S K Jain
Journal:  Indian J Clin Biochem       Date:  2005-07

Review 8.  A review of feline infectious peritonitis virus infection: 1963-2008.

Authors:  Niels C Pedersen
Journal:  J Feline Med Surg       Date:  2009-02-28       Impact factor: 2.015

9.  Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.

Authors:  Nguyen Thi Phuong Dung; Huynh Thi Le Duyen; Nguyen Thi Van Thuy; Tran Van Ngoc; Nguyen Van Vinh Chau; Tran Tinh Hien; Sarah L Rowland-Jones; Tao Dong; Jeremy Farrar; Bridget Wills; Cameron P Simmons
Journal:  J Immunol       Date:  2010-05-12       Impact factor: 5.422

10.  Development and evaluation of an enzyme-linked immunosorbent assay for dengue capsid.

Authors:  Suganya Selvarajah; Udayan Chatterji; Richard Kuhn; Richard Kinney; Subhash G Vasudevan; Philippe Gallay
Journal:  Open Virol J       Date:  2012-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.